Cargando…
Chronic idiopathic axonal neuropathy and pain, treated with the endogenous lipid mediator palmitoylethanolamide: a case collection
Chronic idiopathic axonal polyneuropathy is a frequent diagnosis in patients suffering from idiopathic polyneuropathy and neuropathic pain. No guidelines exist on how to treat these patients. To date, there are no results available from randomized clinical trials, and mostly classical neuropathic an...
Autor principal: | Hesselink, J M Keppel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3775671/ https://www.ncbi.nlm.nih.gov/pubmed/24049461 http://dx.doi.org/10.2147/IMCRJ.S51572 |
Ejemplares similares
-
Therapeutic utility of palmitoylethanolamide in the treatment of neuropathic pain associated with various pathological conditions: a case series
por: Hesselink, Jan M Keppel, et al.
Publicado: (2012) -
Treatment of chronic regional pain syndrome type 1 with palmitoylethanolamide and
topical ketamine cream: modulation of nonneuronal cells
por: Keppel Hesselink, Jan M, et al.
Publicado: (2013) -
Palmitoylethanolamide, a neutraceutical, in nerve compression syndromes: efficacy and safety in sciatic pain and carpal tunnel syndrome
por: Keppel Hesselink, Jan M, et al.
Publicado: (2015) -
Topical phenytoin for the treatment of neuropathic pain
por: Kopsky, David J, et al.
Publicado: (2017) -
Evolution in pharmacologic thinking around the natural analgesic palmitoylethanolamide: from nonspecific resistance to PPAR-α agonist and effective nutraceutical
por: Hesselink, Jan M Keppel
Publicado: (2013)